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e have found that key mitotic regulators show
distinct patterns of degradation during exit from
mitosis in human cells. Using a live-cell assay for
proteolysis, we show that two of these regulators, polo-like
kinase 1 (Plk1) and Aurora A, are degraded at different
times after the anaphase-promoting complex/cyclosome
(APC/C) switches from binding Cdc20 to Cdh1. Therefore,
events in addition to the switch from Cdc20 to Cdh1 control
the proteolysis of APC/C
 
Cdh1
 
 substrates in vivo. We have
W
 
identiﬁed a putative destruction box in Plk1 that is required
for degradation of Plk1 in anaphase, and have examined
the effect of nondegradable Plk1 on mitotic exit. Our results
show that Plk1 proteolysis contributes to the inactivation of
Plk1 in anaphase, and that this is required for the proper
control of mitotic exit and cytokinesis. Our experiments
reveal a role for APC/C-mediated proteolysis in exit from
mitosis in human cells.
 
Introduction
 
In animal cells, the regulated proteolysis of cyclin A, cyclin
B1, and securin during mitosis are all essential for the proper
timing of events leading up to separation of sister chromatids
at the onset of anaphase (den Elzen and Pines, 2001; Geley et
al., 2001; Stemmann et al., 2001; Hagting et al., 2002;
Leismann and Lehner, 2003). Proteolysis of these key mitotic
regulators is mediated by the anaphase-promoting complex/
cyclosome (APC/C) ubiquitin ligase and requires the acti-
vating subunit Cdc20/fizzy (Morgan, 1999; Peters, 2002).
Cdc20 activity is replaced by that of Cdh1/fizzy-related during
mitotic exit, and the role of Cdh1 in suppressing mitotic
cyclins is essential to establish the G1 phase of the cell cycle
(for review see Peters, 2002). However, this switch from
Cdc20 to Cdh1 is thought to allow degradation of many
additional substrates because APC/C
 
Cdh1
 
 has been shown to
have broader substrate specificity than APC/C
 
Cdc20
 
 (Fang et
al., 1998; Pfleger and Kirschner, 2000; Hagting et al., 2002;
Zur and Brandeis, 2002). Amongst the regulators degraded
during mitotic exit in mammalian cells are Cdc20, the polo-
like kinase 1 (Plk1), the Aurora kinases, and the CENP-E
motor protein (Brown et al., 1994; Weinstein, 1997; Ferris et
al., 1998; Honda et al., 2000). However, it has not been
shown whether these substrates are all degraded as soon as the
APC/C switches from its Cdc20- to Cdh1-activated form, or
whether they are degraded at distinct times, perhaps to coor-
dinate exit from mitosis. In budding yeast, mitotic exit is under
the tight control of the mitotic exit network (Morgan, 1999),
a signaling cascade required for the activation of Cdh1 by
the Cdc14 phosphatase that can be restrained by a Bub2-
dependent checkpoint that monitors the position of the spindle
(Li, 1999; Pereira et al., 2000). An equivalent network in
mammalian cells has yet to be identified, although homologues
of some of the components, such as Cdc14, have been identi-
fied. In human cells, a homologue of the spindle checkpoint
protein Mad2 (Mad2B) has been shown to inhibit Cdh1 in
vitro (Chen and Fang, 2001), but the role of Mad2B in mitotic
exit, if any, is not known.
Here, we have begun to examine the role and regulation of
proteolysis during mitotic exit in mammalian cells, through
studying fluorescent protein (FP)–tagged substrates in living
cells. We find that different mitotic regulators are degraded at
different times, indicating that APC/C
 
Cdh1
 
 activity may be
modulated to coordinate mitotic exit and cytokinesis.
 
Results
 
Initially, we investigated whether it was possible to identify
differences in the degradation patterns of substrates by ana-
lyzing immunoblots of endogenous protein levels in HeLa
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cell extracts. Analysis of extracts from cells synchronized
through mitotic exit by release from nocodazole-induced ar-
rest showed that the degradation of APC/C
 
Cdh1
 
 substrates
was not concerted (Fig. 1). Plk1 disappeared from cell ex-
tracts earlier than Aurora A and CENP-E, whereas Aurora B
appeared to be degraded later and was still detectable in G1
cell extracts (Fig. 1 A). In further experiments, p55
 
Cdc20
 
 ap-
peared to be degraded earlier than Plk1 (Fig. 1 B). PRC1
and BubR1, proposed to be late mitotic substrates (Jiang et
al., 1998; Chan et al., 1999), were not significantly degraded
after release from nocodazole (Fig. 1 A). Although this anal-
ysis confirmed that specific mitotic regulators were degraded
during exit from mitosis and indicated that they were de-
graded with different kinetics, it did not show exactly when
degradation of the substrates began. Moreover, we found
that the rate of recovery from the nocodazole block varied
between cells. Therefore, we tagged substrates with FPs to
use as markers for the endogenous substrates in single-cell
analyses of degradation.
We began by analyzing Plk1. A GFP-Plk1 chimera had
previously been validated as a marker for the localization of
endogenous human Plk1 (Arnaud et al., 1998), so we exam-
ined whether it was also a suitable marker for the mitotic
degradation of Plk1. We injected G2 phase HeLa cells with
a cDNA encoding Plk1 tagged at its amino terminus with
EYFP (YFP-Plk1), and recorded the fluorescence of mitotic
cells by time-lapse imaging. YFP-Plk1 fluorescence started to
decline at the beginning of anaphase (Fig. 2), timing that
was clearly distinguishable from the decrease in cyclin B1-
CFP in metaphase (Clute and Pines, 1999; Hagting et al.,
2002; Fig. 2 A; Video 1 and supplemental data, available at
http://www.jcb.org/cgi/content/full/jcb.200309035/DC1).
The onset of Plk1 degradation correlated with its relocaliza-
tion from the kinetochores to the midzone of the mitotic
spindle (Arnaud et al., 1998; Fig. 2 A, time point 3). The
decline in YFP-Plk1 fluorescence was indeed a result of pro-
teolysis because it was blocked by the proteasome inhibitor
MG132 (Fig. 2 B). The onset and rate of YFP-Plk1 degrada-
tion were highly reproducible in this assay (Fig. 2 C), and in
almost all cells, 60–75% of YFP-Plk1 was degraded during
mitotic exit. Cells expressing very high levels of YFP-Plk1
were not able to degrade the protein properly and were un-
able to exit normally from mitosis (see Fig. 5). Using a U20S
cell line stably expressing YFP-Plk1 (Jackman et al., 2003),
we have estimated that the usual levels of expression of YFP-
Plk1 achieved during injection experiments varied from less
than that of endogenous Plk1 to approximately threefold the
endogenous level. The timing of YFP-Plk1 degradation was
identical in U20S cells (unpublished data).
The time at which YFP-Plk1 degradation began appeared
to reflect the switch from APC/C
 
Cdc20
 
 to APC/C
 
Cdh1
 
 at ana-
phase (Hagting et al., 2002). Therefore, we compared the
proteolysis of YFP-Plk1 with an in vivo marker for APC/
C
 
Cdh1
 
. We used a CFP-tagged destruction box (D-box) mu-
tant of securin (db-securin-CFP) that was a substrate for
APC/C
 
Cdh1
 
 but not APC/C
 
Cdc20
 
 in vitro, and whose degrada-
tion in vivo depended on the KEN box motif present in the
amino terminus, and on a decline in cyclin B-Cdk1 activity
(Hagting et al., 2002). db-securin-CFP degradation pre-
ceded that of YFP-Plk1 by several minutes (Fig. 3 A), indi-
cating that the activation of APC/C
 
Cdh1
 
 is not sufficient to
initiate YFP-Plk1 destruction. Our finding that APC/C
 
Cdh1
 
was active before Plk1 degradation began was consistent
with our observation that another APC/C
 
Cdh1
 
 substrate,
p55
 
Cdc20
 
, appeared to be degraded earlier than Plk1 after re-
lease from a nocodazole arrest (Fig. 1 B). However, we were
Figure 1. The disappearance of mitotic 
regulators at exit from mitosis is not 
concerted. (A and B) HeLa cells were syn-
chronized in prometaphase by a nocoda-
zole block after a thymidine/aphidicolin 
double block/release (see Materials and 
methods). Mitotic cells were harvested 
by shake-off, washed, and replated in 
the absence of nocodazole. At the time 
points indicated, samples were processed 
for immunoblot analysis of the indicated 
proteins. (A) Parallel samples were pro-
cessed for analysis of DNA content by 
flow cytometry, and the M-phase/G1 
distribution of each cell population is 
indicated. Protein loading was assayed 
by Ponceau S staining and is equivalent 
for each time point. (B) Extracts were 
probed with antibodies against p55
Cdc20 
and Plk1, and with  -tubulin as a loading 
control. We found that the time required 
for recovery from nocodazole varied 
between each of the three experiments 
we performed (compare Plk1 degradation 
in A and B), but that Cdc20 levels always 
fell before those of Plk1. ns, extracts from 
nonsynchronized cells. Note that com-
paring levels in unsynchronized cells to 
mitotic cells in A indicates that PRC1 (but 
not BubR1) levels are cell cycle regulated. 
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unable to verify this in vivo because FP-Cdc20 was a very
poor substrate for APC/C
 
Cdh1
 
 (unpublished data).
We were interested in comparing the timing of destruc-
tion of other APC/C
 
Cdh1
 
 substrates with Plk1, and selected
Aurora A, which was recently shown to be an APC/C
 
Cdh1
 
substrate both in vitro and in vivo (Castro et al., 2002; Lit-
tlepage and Ruderman, 2002; Taguchi et al., 2002). Degra-
dation of Aurora A-YFP began 6–12 min after the start of
anaphase, always after that of CFP-Plk1 (Fig. 3 B). Aurora A
consistently began to be degraded at the moment of maxi-
mum spindle elongation in anaphase B (Fig. 3 B, see also
Fig. 4 C), when microtubule-associated Aurora A-YFP ap-
peared on the central spindle, and fluorescence at the spindle
pole diminished (Fig. 3 B, time point 2; Videos 2 and 3, and
supplemental data, available at http://www.jcb.org/cgi/content/
full/jcb.200309035/DC1). In contrast to Plk1 degradation,
which stopped once cells entered G1 phase, Aurora A-YFP
degradation continued to completion (Fig. 3 B, see also Fig.
2 C). The distinct patterns of disappearance of Plk1 and Au-
rora A indicate that the degradation of different APC/C
 
Cdh1
 
substrates is tied to specific events during mitotic exit.
Having found that there was an ordered proteolysis of
APC/C
 
Cdh1
 
 substrates during anaphase, we wished to deter-
mine whether APC/C
 
Cdh1
 
-mediated proteolysis played a role
in mitotic exit by blocking degradation of one of its sub-
strates. We examined the Plk1 sequence for motifs that
might direct its mitotic degradation and identified an RxxL
D-box-like motif (Glotzer et al., 1991) between the kinase
and polo-box domains of Plk1 (Fig. 4 A). This motif is con-
served in all mammalian orthologues of Plk1, in 
 
Xenopus
Figure 2. Plk1 degradation begins at the start of anaphase and is pro-
teasome dependent. (A) HeLa cells synchronized in late G2 phase were 
coinjected with cDNAs encoding YFP-Plk1 and cyclin B1-CFP, and fluores-
cence in mitotic cells was recorded by time-lapse imaging. Fluorescence 
in whole cells was measured and plotted as pixel values. The degradation 
curves shown are representative of at least seven cells in at least two separate 
experiments. YFP-Plk1–associated fluorescence at the various stages of mito-
sis is shown (images taken from Video 1, available at http://www.jcb.org/cgi/
content/full/jcb.200309035/DC1). 1, prophase; 2, prometaphase; 3, early 
anaphase; 4, late anaphase; 5, telophase. (B) MG132 at a final concentration 
of 50  M was added to a cell in anaphase during time-lapse imaging of cells 
expressing YFP-Plk1 as in A. Its degradation curve has been superimposed 
on that of a control cell in the dish, which had completed mitosis before 
addition of MG132. (C) YFP fluorescence in cells expressing different levels 
of YFP-Plk1. Degradation of YFP-Plk1 at anaphase was measured in  20 
cells, with or without coexpression of cyclin B1-CFP, in  10 separate 
experiments. Here, natural log values of fluorescence from representative 
cells have been plotted to show that the rate of degradation does not vary 
between cells, and is not affected by coexpression of cyclin B1. The vertical 
line in C indicates the average time of anaphase onset and is accurate 
within 90 s for each cell. 
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Plx1, and in 
 
Drosophila
 
 polo, but is not present in fission
yeast plo1, whose levels do not fluctuate during the cell cycle
(Mulvihill et al., 1999). Moreover, this motif is not con-
served in mammalian Plk3/Prk that is not degraded at mito-
sis (Ouyang et al., 1997; Ferris et al., 1998; Fig. S1 and sup-
plemental data, available at http://www.jcb.org/cgi/content/
full/jcb.200309035/DC1). Therefore, this motif appeared
to be a good candidate to act as a Plk1 D-box. We made ala-
nine substitutions at the conserved RxxL positions of the pu-
tative D-box sequence (R337A, L340A), and found that this
mutant of Plk1 (YFP-db-Plk1) was stable in anaphase (Fig.
4 B), and the dynamic localization of this protein during mi-
tosis was indistinguishable from that of the wild-type pro-
tein (Video 4 and supplemental data, available at http://
www.jcb.org/cgi/content/full/jcb.200309035/DC1). Mu-
tating an adjacent sequence (E348A, N349A) had no effect
(unpublished data). Immunofluorescence analysis confirmed
that the untagged version of the R337A, L340A mutant (db-
Plk1) was stable in mitosis because it was present at high lev-
els in newly divided cells (Fig. S2 and supplemental data).
We conclude that R337 defines a D-box that directs Plk1
destruction in anaphase. YFP-db-Plk1 did not prevent Au-
rora A-YFP being degraded, showing that the degradation of
later substrates did not depend on prior degradation of Plk1,
and confirming that the stabilization of Plk1 was not due to
a general inhibition of APC/C
 
Cdh1
 
 (Fig. 4 C).
Nondegradable Plk1 frequently interfered with exit from
mitosis. Furthermore, cells expressing high levels of YFP-
Plk1 frequently were unable to degrade the protein prop-
erly, and in these cells mitotic exit was perturbed (Fig. 5).
In these cells, anaphase and cytokinesis were slowed down;
spindle elongation was impaired and cleavage furrow in-
gression was delayed, with many cells exhibiting extensive
blebbing of the plasma membrane during this delay (Fig. 5
A). Although spindle elongation was frequently slow, max-
imum elongation (measured as the extent of sister chroma-
tid separation observed by differential interference contrast
[DIC] microscopy) was usually unaffected. There was fre-
quently a delay after maximum spindle elongation before
the cleavage furrow began to ingress, whereas these events
occurred concurrently in uninjected cells. We did not
observe chromosome decondensation during this delay;
therefore, both mitotic exit and cytokinesis appeared to be
delayed. The delay in mitotic exit in cells unable to de-
grade Plk1 was frequently accompanied by abnormal
movement of the anaphase spindle during prolonged cleav-
age furrow ingression (Videos 5 and 6 and supplemen-
tal data, available at http://www.jcb.org/cgi/content/full/
jcb.200309035/DC1), indicating that the coordination
between microtubule and actin cytoskeletons might be
compromised in these cells. Overexpression of Plk1 or
YFP-Plk1 also delayed mitosis before anaphase, and this
delay was aggravated by a constitutively active form of the
kinase, but not by nondegradable forms. However, the de-
lay in mitotic exit was independent of the total time spent
in mitosis (unpublished data).
Figure 3. Different APC
Cdh1 substrates are degraded at different times. 
(A and B) HeLa cells synchronized in late G2 phase were coinjected with 
cDNAs encoding YFP-Plk1 and db-securin-CFP (A; securin  61-68) or 
Aurora A-YFP and CFP-Plk1 (B), and fluorescence in mitotic cells was 
recorded by time-lapse imaging. Fluorescence in whole cells was mea-
sured and plotted as pixel values. In A, the timing of anaphase onset 
has been estimated as 6 min before spindle elongation in anaphase B 
(because these cells do not separate sister chromatids). The degradation curves shown are representative of at least four cells in two separate 
experiments (A) and ten cells in three separate experiments (B). Aurora A-YFP–associated fluorescence at the various stages of mitosis is shown. 
1, metaphase; 2, early anaphase; 3, mid anaphase; 4, late anaphase. See also Videos 2 and 3 (available at http://www.jcb.org/cgi/content/full/
jcb.200309035/DC1) for further examples. 
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We sought to quantify the delay in mitotic exit by mea-
suring the total time (t) taken from sister chromatid separa-
tion to the completion of cleavage in cells injected with ei-
ther YFP-tagged or untagged versions of Plk1 (Fig. 5 A).
Injecting cells with YFP alone had no effect on mitotic exit
(unpublished data). We found that there was a large varia-
tion in exit times in cells injected with nondegradable Plk1,
best illustrated by box plots (Fig. 5, B and C), with some
cells taking three times longer than the control mean value.
Untagged, nondegradable Plk1 (Fig. 5 B; db-Plk1, un-
tagged) consistently had a more pronounced effect on mi-
totic exit than wild-type Plk1, indicating that Plk1 proteoly-
sis might be required for normal mitotic exit.
In budding yeast, redundant pathways have been dem-
onstrated to inactivate mitotic cyclin-Cdks after mitosis:
APC
 
Cdh1
 
-mediated degradation is not required for cell viabil-
ity as long as the Cdk inhibitor Sic1 is present (Schwab et
al., 1997; Visintin et al., 1997). Thus, we considered the
possibility that there might be parallel pathways to inactivate
APC
 
Cdh1
 
 targets during exit from mammalian mitosis. Be-
cause Plks are activated in mitosis by phosphorylation at a
threonine residue in the activation loop (Kelm et al., 2002),
we inserted the activating T210D mutation (Qian et al.,
1999) at this site to generate a version of Plk1 that could not
be inactivated by dephosphorylation. We found that, like
nondegradable db-Plk1, the constitutively active T210D-
Plk1 delayed mitotic exit compared with wild-type Plk1.
Furthermore, a double mutant of Plk1 that was constitu-
tively active and nondegradable, dbT210D-Plk1, signifi-
cantly increased the frequency with which we observed this
phenotype (Fig. 5 B, see P values).
We thought that the large variation in mitotic exit times
(Fig. 5 B) might arise from variability between cells in the
level of Plk1, which we were unable to measure because the
proteins were not fluorescently tagged. Therefore, we exam-
ined mitotic exit times in cells expressing YFP-tagged Plk1,
where we could select cells expressing comparable levels of
the different constructs. In these cells, we observed similar
delays in mitotic exit, but also saw a similar variation in mi-
totic exit times (Fig. 5 C). Additionally, we found an in-
creased delay in cells expressing wild-type YFP-Plk1 com-
pared with untagged Plk1. This indicated that the YFP tag
could reduce the rate of degradation of the protein. Perhaps
because of this, mutating the D-box alone in YFP-Plk1 had
Figure 4. Plk1 degradation in anaphase depends on a D-box-like motif. (A) The sequences of Plk1 homologues were aligned (supplemental 
data and Fig. S2, available at http://www.jcb.org/cgi/content/full/jcb.200309035/DC1). R
337xxL is the only candidate D-box not conserved in 
Plk2 and Plk3. R337 and L340 were mutated to alanine (R337A, L340A) to create YFP-db-Plk1. (B and C) HeLa cells synchronized in late G2 
phase were coinjected with cDNAs encoding YFP-db-Plk1 and CFP-Plk1 wild-type (B) or CFP-db-Plk1 and Aurora A-YFP (C), and fluorescence 
in mitotic cells was recorded by time-lapse imaging. Fluorescence in whole cells was measured and plotted as pixel values. YFP-db-Plk1 was 
found to be stable in at least 20 anaphase cells in eight separate experiments, one of which is shown in Video 4 (available at http://www.jcb.org/
cgi/content/full/jcb.200309035/DC1). The experiment shown in C is representative of five cells in two separate experiments. 
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Figure 5. Nondegradable Plk1 causes a delay in mitotic 
exit. (A) Time-lapse DIC images of mitotic exit for a normal 
(uninjected) HeLa cell and for one injected in G2 phase with 
a YFP-Plk1 expression plasmid. These cells were filmed 
concurrently in the same dish (see Materials and methods). 
t, mitotic exit time (see below). (B and C) Box plot distribu-
tions of mitotic exit times for uninjected cells and cells 
injected with cDNAs encoding untagged wt-, db-, T210D-, 
dbT210D-Plk1 (B), or YFP-tagged versions of the same 
constructs (C). A YFP expression plasmid was used as a 
marker for cells injected with untagged constructs (B). In 
these distributions, the maximum and minimum values, the 
interquartile range (marked by boxes), and the median value 
(marked by horizontal line) for mitotic exit times in each 
population are shown. Suspected outliers are shown as open 
circles, an outlier as a filled circle. P values for each popu-
lation of cells expressing a Plk1 mutant, compared with that 
expressing the wild-type version, are indicated. The software 
used is available online upon request. (D) Degradation 
curves (plotted as natural log values) for YFP-Plk1 and YFP-
T210D-Plk1 in cells showing impaired mitotic exit. Cells 
expressing either YFP-Plk1 (filled circles) or YFP-T210D-Plk1 
(open circles) were compared from the same experiment. 
Cells in which mitotic exit took  24 min are indicated by 
arrowheads. This figure is representative of three separate 
experiments. 
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a less significant effect on mitotic exit times (Fig. 5 C). To
confirm the link between Plk1 degradation and mitotic exit
times in cells expressing YFP-tagged Plk1, we examined the
rates of YFP-Plk1 and YFP-T210D-Plk1 degradation and
correlated this with the time taken to exit mitosis. We found
that degradation was systematically impaired in cells display-
ing very prolonged mitotic exit times (Fig. 5 D). This oc-
curred more frequently in YFP-T210D-Plk1 cells than in
YFP-Plk1 cells, indicating that inactivation of Plk1 in ana-
phase may be required for its proper degradation.
 
Discussion
 
We have presented evidence that normal exit from mitosis re-
quires the inactivation of Plk1, and that this can be either by
degradation or by dephosphorylation. Thus, APC/C
 
Cdh1
 
-
dependent proteolysis appears to play an important role in
the proper exit from mitosis. However, because there are likely
to be parallel pathways to inactivate mitotic kinases, there may
not be any one mitotic regulator whose degradation is essen-
tial for mitotic exit. Indeed, in early embryos, mitotic cycles
occur in the absence of Cdh1 expression (Sigrist and Lehner,
1997; Lorca et al., 1998). We suggest that degradation di-
rected by APC/C
 
Cdh1
 
 increases the efficiency with which mi-
totic regulators are inactivated at the end of mitosis. Consis-
tent with this suggestion, Cdh1
 
 
 
/
 
 
 
 DT40 cells, although
viable, show prolonged mitotic exit (Sudo et al., 2001).
Why should there be a requirement for Plk1 inactivation
during anaphase? This appears to contradict the well-docu-
mented requirement for Plk activity in cytokinesis and mitotic
exit (for review see Bahler et al., 1998; Carmena et al., 1998;
Heitz et al., 2001; Lee et al., 2001; Song and Lee, 2001; Mul-
vihill and Hyams, 2002; Seong et al., 2002). We propose that
in addition to being required for assembly of the contractile
ring, Plk1 may inhibit cleavage furrow ingression in mamma-
lian cells, perhaps to ensure that ingression cannot occur be-
fore anaphase (Shuster and Burgess, 2002). According to the
model most recently proposed (Dechant and Glotzer, 2003),
this inhibition could be achieved by regulating microtubule
bundling in the central spindle. Work published by Neef et al.
(2003) during the preparation of this manuscript allows us to
identify the kinesin-like protein MKLP-2 as a candidate to
mediate the inhibitory effect of Plk1 on cell cleavage. MKLP-2
localizes to the central spindle during anaphase in a complex
with Plk1, and has microtubule bundling activity in vitro that
can be negatively regulated by Plk1.
Although previous work by others has described the ap-
pearance of multinucleated cells after transfection of Plk1
(Mundt et al., 1997), a failure of cytokinesis is a rare event
under our experimental conditions, perhaps reflecting the
lower levels of expression achieved with microinjection. We
find that almost all cells attempt cytokinesis within 50 min
of anaphase. This 50-min interval corresponds to the previ-
ously described period of “cortical contractility,” or C-phase
(Martineau et al., 1995; Canman et al., 2000). C-phase can
be extended by inhibiting proteolysis with MG132 in the
presence of blebbistatin, an inhibitor of myosin II (Straight
et al., 2003), indicating that the length of C-phase is regu-
lated by proteolysis. Our results show that the relevant sub-
strate does not appear to be Plk1 because nondegradable
Plk1 delays cytokinesis without altering the length of
C-phase (Fig. 5, B and C). Moreover, cells starting with ex-
cess Plk1 almost always eventually perform cytokinesis.
Thus, we suggest that C-phase is not just the window of op-
portunity during which cytokinesis can occur, but also rep-
resents the maximum period for which cytokinesis can be
delayed in response to inappropriate conditions.
Our preliminary analyses indicate that the delay in cytoki-
nesis correlates with delayed recruitment of cleavage furrow
components (unpublished data). An understanding of the
pathways that coordinate cytokinesis with mitotic exit re-
mains an important challenge, and our finding that there is
ordered degradation of mitotic regulators as cells exit from
mitosis may provide important clues to these pathways.
 
Materials and methods
 
Cell culture and synchronization
 
HeLa cells were cultured and synchronized for microinjection in G2 phase
as described previously (Clute and Pines, 1999). Mitotic cells for the exper-
iment shown in Fig. 1 were prepared by a modified version of the synchro-
nization regime, where cells were released from aphidicolin (Sigma-
Aldrich) into medium containing 400 ng/
 
 
 
l nocodazole (Sigma-Aldrich)
and incubated for 12 h before harvesting by shake-off. Mitotic cells were
washed three times in ice-cold PBS and replated in medium prewarmed to
37
 
 
 
C. Cell cycle distributions of cell populations at different time points
were calculated by analysis of DNA content on a FACsort™ Flow Cytome-
ter (Becton Dickinson) after propidium iodide staining as described previ-
ously (Lindon et al., 2000). MG132 was obtained from Calbiochem.
 
Immunoblotting
 
Extracts were made from cell populations at the indicated time points after
nocodazole release. Cells were washed with PBS. Extracts prepared by ad-
dition of boiling SDS sample buffer directly to culture dishes (for reat-
tached cells in G1), and to cells pelleted from the culture medium (for un-
attached mitotic cells), were pooled. Samples were heated at 
 
 
 
95
 
 
 
C for 3
min and then sheared through 21G needles. Approximately 5 
 
 
 
g of each
sample was blotted by the standard semi-dry transfer technique onto Im-
mobilon™-P (Millipore). Filters were processed for immunoblotting using
standard techniques. Rabbit polyclonal antisera used were raised against
(1) human Plk1 amino-terminal peptide (Upstate Biotechnology); (2) cyclin
B1 (Hagting et al., 1998); (3) human AIK1 (Aurora A) and mouse AIK2
amino terminus (Aurora B; both gifts of Peter Donovan, Thomas Jefferson
University, Philadelphia, PA); (4) BubR1 (a gift of Gordon Chan, Fox Chase
Cancer Center, Philadelphia, PA); (5) CENP-E (a gift of Tim Yen, Fox Chase
Cancer Center, Philadelphia, PA); and (6) PRC1 (a gift of Tony Hunter, Salk
Institute, La Jolla, CA). Goat polyclonal anti–human p55
 
Cdc20
 
 was obtained
from Santa Cruz Biotechnology, Inc.
 
Construction of cDNA plasmids
 
Plk1 cDNA was cloned from pCMX-GFP10c-Plk1 (Arnaud et al., 1998)
into pEYFP-C3 (CLONTECH Laboratories, Inc.) for expression as a fusion
protein with YFP at the amino terminus, and into pcDNA3 for expression
as an untagged protein.
New point mutations were constructed by whole-plasmid PCR using
 
Pfu
 
 DNA polymerase (Stratagene) and confirmed by automated sequenc-
ing. Constitutively active versions of Plk1 were constructed by swapping in
sequences from pRcCMV-Plk1-T210D (a gift of Erich Nigg, Max Planck In-
stitute, Martinsried, Germany).
Human Aurora A sequence was generated by PCR from pCRUZ-myc-
Aurora A (a gift of Claude Prigent, University of Rennes, Rennes, France)
and was cloned into pEYFP-N1, and is expressed as a fusion protein linked
at its carboxy terminus to YFP. pECFP-N1-cyclin B1 and pECFP-N1-
securin
 
 
 
61-68 have been described previously (Hagting et al., 2002). His-
tone 2B-YFP was the gift of Claire Acquaviva (Wellcome Trust/Cancer Re-
search UK Institute, Cambridge, UK). Further details of all constructs used
are available upon request.
 
Microinjection and time-lapse imaging and analysis
 
Cells were injected and analyzed using time-lapse DIC fluorescence mi-
croscopy with different filter cubes to distinguish YFP- and CFP-associated 
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fluorescence as described previously (Clute and Pines, 1999; Hagting et
al., 1999, 2002), but with the addition of a programmable XY stage (Prior
Scientific Instruments Ltd.) to allow concurrent filming of several fields of
cells. Images were collected every 2 or 3 min and saved in IP Lab Spec-
trum (Scanalytics) format as 16-bit data using a reference look-up table
with a preset linear pixel intensity scale. ImageJ software (National Insti-
tutes of Health; modified by Jean-Yves Thuret) was used for quantifying
CFP and YFP fluorescence. Fluorescence levels in whole cells were mea-
sured as pixel values within a region of interest (ROI) drawn around each
cell and applied to all images in a series. The ROI drawn in each case was
large enough to allow for changing cell shape during mitotic exit. Because
we subtracted background pixel values from our measured values, this
method gave accurate measurements of total cell fluorescence. DIC im-
ages were used to determine the onset of anaphase. Images were then con-
verted to PICT format and exported to Adobe Photoshop
 
®
 
, or processed via
ImageJ to make QuickTime
 
®
 
 movies.
 
Online supplemental material
 
A sequence alignment of human Plk family members, showing the position
of the nonconserved D-box motif, is shown in Fig. S1. Fig. S2 shows anti-
Plk1 staining of G1 cells injected with untagged versions of Plk1, and con-
firms that untagged db-Plk1 is not degraded in mitosis and/or G1 phase.
Videos available online show examples of cells degrading Plk1 (Video 1),
Aurora A (Video 2), or both (Video 3), cells expressing nondegradable Plk1
(Video 4), and cells exhibiting delayed mitotic exit in response to nonde-
graded Plk1 (Videos 5 and 6). All supplemental videos, supplemental fig-
ures, and an associated Materials and methods section are available online
at http://www.jcb.org/cgi/content/full/jcb.200309035/DC1.
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